RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Bellevue, NE · Omaha, NE · +452 more sites
Leukemia clinical trials in Omaha, NE
16 recruiting leukemia studies with a site in Omaha, NE.
RecruitingPhase 2NCT06317662
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Sponsor: National Cancer Institute (NCI)
Omaha, NE · +114 more sites
RecruitingPhase 2NCT05554393
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Bellevue, NE · Omaha, NE · +172 more sites
RecruitingPhase 1NCT06528301
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Sponsor: Umoja Biopharma
Omaha, NE · +6 more sites
RecruitingPhase not listedNCT07143669
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Sponsor: Blueprint Medicines Corporation
Lincoln, NE · Omaha, NE · +23 more sites
RecruitingPhase 3NCT07277231
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Sponsor: BeOne Medicines
Omaha, NE · +21 more sites
RecruitingPhase 3NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Sponsor: Children's Oncology Group
Omaha, NE · +184 more sites
RecruitingPhase 1 / Phase 2NCT03104491
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Sponsor: Leland Metheny
Omaha, NE · +6 more sites
RecruitingPhase 1 / Phase 2NCT04726241
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Sponsor: PedAL BCU, LLC
Omaha, NE · +162 more sites
RecruitingPhase not listedNCT05702645
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Sponsor: Children's Oncology Group
Omaha, NE · +70 more sites
RecruitingPhase 1NCT06001788
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Kura Oncology, Inc.
Omaha, NE · +37 more sites
RecruitingPhase not listedNCT02012699
Integrated Cancer Repository for Cancer Research
Sponsor: University of Nebraska
Hastings, NE · Norfolk, NE · North Platte, NE · +39 more sites
RecruitingPhase 1 / Phase 2NCT04068597
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Sponsor: CellCentric Ltd.
Omaha, NE · +4 more sites
RecruitingPhase not listedNCT05978141
A Registry for People With T-cell Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Omaha, NE · +25 more sites
RecruitingPhase 1 / Phase 2NCT04329728
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Sponsor: AVM Biotechnology Inc
Omaha, NE · +10 more sites
RecruitingPhase 4NCT06876649
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Sponsor: Eli Lilly and Company
Omaha, NE · +19 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.